Caron Treatment Centers Names Dr. Adam Scioli as Chief Medical Officer

Wernersville, PA – May 20, 2024 – Caron Treatment Centers, a nonprofit behavioral healthcare leader for almost 70 years dedicated to transforming lives through treatment, research, prevention and addiction medical education, announced the appointment of Adam Scioli, D.O., DFAPA, FASAM, FAOAAM, to Chief Medical Officer (CMO). Dr. Scioli will serve on Caron’s Executive Leadership Team, reporting directly to Caron Chief Executive Officer John Driscoll.

As Chief Medical Officer, Dr. Scioli will oversee all medical services at Caron, including psychiatry, psychology and neuropsychology as well as Caron’s expanded neurocognitive services. Caron currently operates two addiction-focused medical centers – The Carol and Ray Neag Center in Pennsylvania and The Keele Center in Florida. Dr. Scioli also oversees Caron’s research program at the Fran and Doug Tieman Center for Research, as well as the Addiction Medicine Fellowship program and Caron’s medical education efforts. In addition to these efforts, Dr. Scioli is a leader on Caron’s interdisciplinary Neurorestorative Health Program which focuses on optimizing and restoring brain health functionality compromised by substance use and issues such as trauma, anxiety and depression.

“While this promotion is a well-deserved recognition of Adam’s significant contributions at Caron, it also demonstrates our commitment to treating the disease of substance use disorder (SUD) as the brain disease it is,” said John Driscoll, CEO of Caron. “The role of Chief Medical Officer has a long history at Caron, reflecting our dedication to healthcare and ensuring consistency of medical philosophy and care throughout the Caron continuum. Adam’s leadership will enable Caron to continue implementing evidence-based and medically appropriate treatments for their substance use and behavioral health disorders, while helping us to advance the treatment of these diseases at its root – the brain. With individuals presenting in treatment with more complex and co-morbid conditions at a greater rate than before, the medical sophistication that Adam and his team provide and their approach to these diseases are invaluable to providing this lifesaving, transformational healthcare.”

“We’re excited to elevate Adam to this important role,” continued Driscoll. “He’s already spearheading Caron’s brain health and neurorestorative care initiative which will transform addiction treatment.”

“I am honored by the opportunity to further advance the practice of addiction medicine, both here and throughout the treatment sector,” commented Dr. Scioli. “Substance Use Disorders are diseases, and they need to be treated as such. Medical research is rapidly advancing our understanding of these diseases and how they affect the brain, and Caron is committed to incorporating advances in medicine into clinical practice in the treatment of SUD.”

Dr. Scioli has been a medical leader at Caron Treatment Centers since July 2015, most recently serving as the corporate medical director and head of psychiatry at Caron.

Dr. Scioli is a graduate of the University of Pennsylvania and New York College of Osteopathic Medicine. He completed an internship at St. Barnabas Hospital in the Bronx, New York and later completed his psychiatry residency training at Einstein Medical Center in Philadelphia, where he was chief resident for two years and was conferred the title of Distinguished Laughlin Fellow for professional achievement, dedication and scholarship. Dr. Scioli simultaneously completed fellowship training through the Psychoanalytic Center of Philadelphia, where his work focused on the relationship between addiction and attachment.

Dr. Scioli is board-certified by the American Board of Psychiatry and Neurology and the American Osteopathic Board of Neurology and Psychiatry. Additionally, he is board-certified in addiction medicine through the American Board of Prevention Medicine and the American Osteopathic Board of Neurology and Psychiatry. Dr. Scioli is a distinguished fellow of the American Psychiatric Association and a fellow of both the American Society of Addiction Medicine and the American Osteopathic Academy of Addiction Medicine. He also serves as secretary/treasurer on the Board of Trustees of the American Osteopathic Academy of Addiction Medicine and as board chair of the International Doctors in Alcohol Anonymous.

Caron Treatment Centers

Caron Treatment Centers is an internationally recognized nonprofit dedicated to transforming lives through addiction and behavioral healthcare treatment, research, prevention and addiction medicine education. During our almost 70 years Caron has helped thousands of individuals struggling with behavioral health issues, including substance use disorder, begin to manage these brain diseases and find hope. Anchored by two medical centers on our Pennsylvania and Florida campuses and headquartered in Wernersville, Pennsylvania, Caron provides a comprehensive continuum of care that includes medical stabilization and detoxification, residential, partial hospitalization, intensive outpatient, and outpatient programs, as well as Recovery support, family and alumni services. Caron also provides concierge signature treatment for executives, healthcare professionals and older adults and offers Neurorestorative Health Care at our Keele Medical Center in Palm Beach County, Fl. In addition to our Pennsylvania and Florida campuses, Caron provides services in Wyomissing, Pa, Philadelphia, Washington, D.C., Atlanta, and New York City. Caron accepts several major insurance plans and provides financial assistance for those who qualify. For more information, please visit caron.org or @CaronTreatment.

Media Contacts:

Kristin Campbell-Salamone
Corporate Director of PR & Communications, Caron Treatment Centers
kcampbell-salamone@caron.org
215-292-5526

Katie Kennedy
Senior Vice President, Gregory FCA
caron@gregoryfca.com
610-731-1045